• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·002412.SZ
Share

Hunan Hansen Pharmaceutical Co., Ltd. Stocks

CN¥ 6.71Last Updated 15.07.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 445.57M

CN¥ 6.71
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Hunan Hansen Pharmaceutical Co., Ltd. is engaged in the manufacturing and global distribution of a wide array of both traditional Chinese and Western pharmaceutical products. The company's diverse offerings are available in numerous formats, including injectables, oral liquids, tablets, capsules, granules, syrups, decoctions, tinctures, and pills. Its primary operational base is located in Yiyang, China.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.07.2026 11:26

PayPal Shares Surge: Fintech Giant Stripe Offers to Buy It — Reuters

15.07.2026 11:00

China's GDP growth has slowed to a three-year low. What can we expect from Beijing?

15.07.2026 10:25

Morning Roundup: IBM's Worst Day, Stripe Sets Its Sights on PayPal, and an OpenAI Gadget

15.07.2026 09:30

Goldman Sachs: The AI boom has reached the same scale as the dot-com boom, but is following a different trajectory

15.07.2026 08:30

Nuclear fusion projects have raised a record $4.5 billion. Is a new boom underway?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026